Patents by Inventor Wayne Livingston Cody

Wayne Livingston Cody has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperidine derivative rennin inhibitors
    Publication number: 20040204455
    Abstract: Disclosed are piperidine derivatives, their manufacture and use as inhibitors of renin.
    Type: Application
    Filed: March 26, 2004
    Publication date: October 14, 2004
    Inventors: Wayne Livingston Cody, Jeremy John Edmunds, Daniel Dale Holsworth, Noel Aaron Powell
  • Peptidyl calcium channel blockers
    Patent number: 6423689
    Abstract: The present invention provides compounds that block calcium channels having the Formula I shown below. The present invention also provides methods of using the compounds of Formula I to treat stroke, cerebral ischemia, head trauma, or epilepsy and to pharmaceutical compositions that contain the compounds of Formula I.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: July 23, 2002
    Assignees: Warner-Lambert Company, Neurex Corporation
    Inventors: Richard John Booth, Louis Brogley, Wayne Livingston Cody, David Thomas Connor, Harriet Wall Hamilton, John Xiaoqiang He, Lain-Yen Hu, Leonard Joseph Lescosky, Thomas Charles Malone, Laszlo Nadasdi, Michael Francis Rafferty, Bruce David Roth, Diego F. Silva, Yuntao Song, Balazs G. Szoke, Laszlo Urge
  • Compounds inhibiting the association of the PDGF receptor and phosphatidylinositol 3-kinase and their use
    Patent number: 6136798
    Abstract: The present invention provides compounds that inhibit the association of platelet-derived growth factor and phosphatidylinositol 3-kinase. The present invention also provides pharmaceutical compositions that contain a compound that inhibits the association of platelet-derived growth factor and phosphatidylinosital 3-kinase, and methods of treating cancer, restenosis, arthritis, dermatitis, atherosclerosis, vein graft intimal hyperplasia, neointimal hyperplasia of vascular smooth muscle and psoriasis using compounds that inhibit the association of platelet-derived growth factor and phosphatidylinositol 3-kinase.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: October 24, 2000
    Assignee: Warner-Lambert Company
    Inventors: Wayne Livingston Cody, Annette Marian Doherty, Scott R. Eaton, Robert Lee Panek
  • Sulfhydryl containing peptides for treating vascular disease
    Patent number: 5786335
    Abstract: Sulfhydryl containing peptides having the formulaX--A.sub.1 --A.sub.2 --A.sub.3 --A.sub.4 --A.sub.5 --Yinhibit the formation of Lp(a) and thus are useful for treating vascular diseases such as coronary heart disease, myocardial infarction, ischemic stroke, cervical atherosclerosis, cerebral infarction, and restenosis.
    Type: Grant
    Filed: October 31, 1996
    Date of Patent: July 28, 1998
    Assignee: Warner-Lambert Company
    Inventors: Wayne Livingston Cody, Helen Tsenwhei Lee, Randy Ranjee Ramharack, Bruce David Roth, Tomi Sawyer, Drago Robert Sliskovic
  • Endothelin antagonists
    Patent number: 5773414
    Abstract: Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, Raynaud's disease, percutaneous transluminal coronary angioplasty or restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, ischemic bowel disease, and diabetes.
    Type: Grant
    Filed: March 7, 1997
    Date of Patent: June 30, 1998
    Assignee: Warner-Lambert Company
    Inventors: Wayne Livingston Cody, Patricia DePue, Annette Marian Doherty, John Xiaoqiang He, Michael Douglas Taylor
  • Methods of using endothelin antagonists
    Patent number: 5641752
    Abstract: Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, Raynaud's disease, percutaneous transluminal coronary angioplasty or restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, ischemic bowel disease, and diabetes.
    Type: Grant
    Filed: September 30, 1994
    Date of Patent: June 24, 1997
    Assignee: Warner-Lambert Company
    Inventors: Wayne Livingston Cody, Patricia DePue, Annette Marian Doherty, John Xiaoqiang He, Michael Douglas Taylor